[REM sleep and intracranial pressure].

G. Rossi,C. Di Rocco,G. Maira,A. Vignati,M. Caldarelli

1977-09-01

Abstract:

What problem does this paper attempt to address?

Exploring the Roles of Family Members in Women’s Decision to Use Postpartum Healthcare Services from the Perspectives of Women and Health Care Providers

L. Abushaikha,I. Khalaf

DOI: https://doi.org/10.1080/03630242.2014.900526

2014-06-09

Women & Health

Abstract:Although the postpartum period is a significant time in a family’s life, few studies have addressed the lack of continuity of care and service use during the postpartum period. The aim of this study was to explore the roles of family members in Jordanian women’s decision to use postpartum health care services. An exploratory qualitative design was employed to elicit the perspectives of 24 women and 30 health care providers through six focus groups discussions conducted in April 2006. Interviews were transcribed verbatim, translated to English, and analyzed using an inductive content analysis approach. In our study, three roles of family members influencing Jordanian women’s decision to use postpartum health care services emerged: supporter role, opponent role, and active participant in care role. Findings supported the need for a family-centered approach when providing postpartum care to enhance positive family roles and limit negative ones to promote continuity of healthcare services use during the postpartum period.
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus

Jiaqiang Wu,Kangping Yang,Hancheng Fan,Meilin Wei,Qin Xiong

DOI: https://doi.org/10.3389/fendo.2023.1114424

IF: 6.055

2023-05-09

Frontiers in Endocrinology

Abstract:Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by hyperglycemia and insulin resistance. The incidence of T2DM is increasing globally, and a growing body of evidence suggests that gut microbiota dysbiosis may contribute to the development of this disease. Gut microbiota-derived metabolites, including bile acids, lipopolysaccharide, trimethylamine-N-oxide, tryptophan and indole derivatives, and short-chain fatty acids, have been shown to be involved in the pathogenesis of T2DM, playing a key role in the host-microbe crosstalk. This review aims to summarize the molecular links between gut microbiota-derived metabolites and the pathogenesis of T2DM. Additionally, we review the potential therapy and treatments for T2DM using probiotics, prebiotics, fecal microbiota transplantation and other methods to modulate gut microbiota and its metabolites. Clinical trials investigating the role of gut microbiota and its metabolites have been critically discussed. This review highlights that targeting the gut microbiota and its metabolites could be a potential therapeutic strategy for the prevention and treatment of T2DM.

endocrinology & metabolism
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus

Zheng Zhou,Bao Sun,Dongsheng Yu,Chunsheng Zhu

DOI: https://doi.org/10.3389/fcimb.2022.834485

IF: 6.073

2022-02-15

Frontiers in Cellular and Infection Microbiology

Abstract:Type 2 diabetes mellitus (T2DM) is one of the common metabolic diseases in the world. Due to the rise in morbidity and mortality, it has become a global health problem. To date, T2DM still cannot be cured, and its intervention measures mainly focus on glucose control as well as the prevention and treatment of related complications. Interestingly, the gut microbiota plays an important role in the development of metabolic diseases, especially T2DM. In this review, we introduce the characteristics of the gut microbiota in T2DM population, T2DM animal models, and diabetic complications. In addition, we describe the molecular mechanisms linking host and the gut microbiota in T2DM, including the host molecules that induce gut microbiota dysbiosis, immune and inflammatory responses, and gut microbial metabolites involved in pathogenesis. These findings suggest that we can treat T2DM and its complications by remodeling the gut microbiota through interventions such as drugs, probiotics, prebiotics, fecal microbiota transplantation (FMT) and diets.

immunology,microbiology
The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes

Daniel P Baars,Marcos F Fondevila,Abraham S Meijnikman,Max Nieuwdorp

DOI: https://doi.org/10.1016/j.chom.2024.07.017

2024-08-14

Abstract:The inhabitants of our intestines, collectively called the gut microbiome, comprise fungi, viruses, and bacterial strains. These microorganisms are involved in the fermentation of dietary compounds and the regulation of our adaptive and innate immune systems. Less known is the reciprocal interaction between the gut microbiota and type 2 diabetes mellitus (T2DM), as well as their role in modifying therapies to reduce associated morbidity and mortality. In this review, we aim to discuss the existing literature on gut microbial strains and their diet-derived metabolites involved in T2DM. We also explore the potential diagnostics and therapeutic avenues the gut microbiota presents for targeted T2DM management. Personalized treatment plans, driven by diet and medication based on the patient's microbiome and clinical markers, could optimize therapy.
Gut microbiome: A revolution in type II diabetes mellitus

Madhan Jeyaraman,Tejaswin Mariappan,Naveen Jeyaraman,Sathish Muthu,Swaminathan Ramasubramanian,Gabriel Silva Santos,Lucas Furtado da Fonseca,José Fábio Lana

DOI: https://doi.org/10.4239/wjd.v15.i9.1874

2024-08-29

World Journal of Diabetes

Abstract:Type II diabetes mellitus (T2DM) has experienced a dramatic increase globally across countries of various income levels over the past three decades. The persistent prevalence of T2DM is attributed to a complex interplay of genetic and environmental factors. While numerous pharmaceutical therapies have been developed, there remains an urgent need for innovative treatment approaches that offer effectiveness without significant adverse effects. In this context, the exploration of the gut microbiome presents a promising avenue. Research has increasingly shown that the gut microbiome of individuals with T2DM exhibits distinct differences compared to healthy individuals, suggesting its potential role in the disease's pathogenesis and progression. This emerging field offers diverse applications, particularly in modifying the gut environment through the administration of prebiotics, probiotics, and fecal microbiome transfer. These inter-ventions aim to restore a healthy microbiome balance, which could potentially alleviate or even reverse the metabolic dysfunctions associated with T2DM. Although current results from clinical trials have not yet shown dramatic effects on diabetes management, the groundwork has been laid for deeper investigation. Ongoing and future clinical trials are critical to advancing our understanding of the microbiome's impact on diabetes. By further elucidating the mechanisms through which microbiome alterations influence insulin resistance and glucose metabolism, researchers can develop more targeted interventions. The potential to harness the gut microbiome in developing new therapeutic strategies offers a compelling prospect to transform the treatment landscape of T2DM, potentially reducing the disease's burden significantly with approaches that are less reliant on traditional pharmaceuticals and more focused on holistic, systemic health improvements.

endocrinology & metabolism
The Gut Microbial Endocrine Organ in Type 2 Diabetes

William Massey,J Mark Brown

DOI: https://doi.org/10.1210/endocr/bqaa235

IF: 5.051

2020-12-29

Endocrinology

Abstract:Abstract Historically, the focus of type II diabetes mellitus (T2DM) research has been on host metabolism and hormone action. However, emerging evidence suggests that the gut microbiome, commensal microbes that colonize the gastrointestinal tract, also play a significant role in T2DM pathogenesis. Specifically, gut microbes metabolize what is available to them through the host diet to produce small molecule metabolites that can have endocrine-like effects on human cells. In fact, the meta-organismal crosstalk between gut microbe-generated metabolites and host receptor systems may represent an untapped therapeutic target for those at risk for or suffering from T2DM. Recent evidence suggests that gut microbe-derived metabolites can impact host adiposity, insulin resistance, and hormone secretion to collectively impact T2DM progression. Here we review the current evidence that structurally diverse gut microbe-derived metabolites, including short chain fatty acids, secondary bile acids, aromatic metabolites, trimethylamine-N-oxide, polyamines, and N-acyl amides, that can engage with host receptors in an endocrine-like manner to promote host metabolic disturbance associated with T2DM. Although these microbe-host signaling circuits are not as well understood as host hormonal signaling, they hold untapped potential as new druggable targets to improve T2DM complications. Whether drugs that selectively target meta-organismal endocrinology will be safe and efficacious in treating T2DM is a key new question in the field of endocrinology. Here we discuss the opportunities and challenges in targeting the gut microbial endocrine organ for the treatment of diabetes and potentially many other diseases where diet-microbe-host interactions play a contributory role.

endocrinology & metabolism
Gut Microbiota and Nutrition: Strategies for the Prevention and Treatment of Type 2 Diabetes

Maria Sastre,Alessandra Cimbalo,Jordi Mañes,Lara Manyes

DOI: https://doi.org/10.1089/jmf.2022.0154

2024-02-22

Journal of Medicinal Food

Abstract:The prevalence of diabetes has increased in last decades worldwide and is expected to continue to do so in the coming years, reaching alarming figures. Evidence have shown that patients with type 2 diabetes (T2D) have intestinal microbial dysbiosis. Moreover, several mechanisms link the microbiota with the appearance of insulin resistance and diabetes. Diet is a crucial factor related to changes in the composition, diversity, and activity of gut microbiota (GM). In this review, the current and future possibilities of nutrient–GM interactions as a strategy to alleviate T2D are discussed, as well as the mechanisms related to decreased low-grade inflammation and insulin resistance. A bibliographic search of clinical trials in Pubmed, Web of Science, and Scopus was carried out, using the terms "gut microbiota, diet and diabetes." The data analyzed in this review support the idea that dietary interventions targeting changes in the microbiota, including the use of prebiotics and probiotics, can improve glycemic parameters. However, these strategies should be individualized taking into account other internal and external factors. Advances in the understanding of the role of the microbiota in the development of metabolic diseases such as T2D, and its translation into a therapeutic approach for the management of diabetes, are necessary to allow a comprehensive approach.

chemistry, medicinal,nutrition & dietetics,food science & technology
Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus

Leilei Du,Qi Li,Huan Yi,Tingting Kuang,Yi Tang,Gang Fan

DOI: https://doi.org/10.1016/j.biopha.2022.112839

2022-05-01

Abstract:Type 2 diabetes mellitus (T2DM) is one of the most risk factors threatening human health. Although genetic and environmental factors contribute to the development of T2DM, gut microbiota has also been found to be involved. Gut microbiota-derived metabolites are a key factor in host-microbe crosstalk, and have been revealed to play a central role in the physiology and physiopathology of T2DM. In this review, we provide a timely and comprehensive summary of the microbial metabolites that are protective or causative for T2DM, including some amino acids-derived metabolites, short-chain fatty acids, trimethylamine N-oxide, and bile acids. The mechanisms by which metabolites affect T2DM have been elaborated. Knowing more about these processes will increase our understanding of the causal relationship between gut microbiota and T2DM. Moreover, some frontier therapies that target gut microbes and their metabolites to improve T2DM, including dietary intervention, fecal microbiota transplantation, probiotics, prebiotics or synbiotics intervention, and drugging microbial metabolism, have been critically discussed. This review may provide novel insights for the development of targeted and personalized treatments for T2DM based on gut microbial metabolites. More high-quality clinical trials are needed to accelerate the clinical translation of gut-targeted therapies for T2DM.

pharmacology & pharmacy,medicine, research & experimental
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes

Ömrüm Aydin,Max Nieuwdorp,Victor Gerdes

DOI: https://doi.org/10.1007/s11892-018-1020-6

2018-06-21

Current Diabetes Reports

Abstract:Purpose of ReviewThe objective of this review is to critically assess the contributing role of the gut microbiota in human obesity and type 2 diabetes (T2D).Recent FindingsExperiments in animal and human studies have produced growing evidence for the causality of the gut microbiome in developing obesity and T2D. The introduction of high-throughput sequencing technologies has provided novel insight into the interpersonal differences in microbiome composition and function.SummaryThe intestinal microbiota is known to be associated with metabolic syndrome and related comorbidities. Associated diseases including obesity, T2D, and fatty liver disease (NAFLD/NASH) all seem to be linked to altered microbial composition; however, causality has not been proven yet. Elucidating the potential causal and personalized role of the human gut microbiota in obesity and T2D is highly prioritized.

endocrinology & metabolism
Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes

Tiantian Zhu,Mark O Goodarzi

DOI: https://doi.org/10.1007/s13668-020-00307-3

Abstract:Purpose of review: An increasing body of evidence suggests that the gut microbiome influences the pathogenesis of insulin resistance and type 2 diabetes (T2D). In this review, we will discuss the latest findings regarding the mechanisms linking the gut microbiome and microbial metabolites with T2D and therapeutic approaches based on the gut microbiota for the prevention and treatment of T2D. Recent findings: Alterations in the gut microbial composition are associated with the risk of T2D. The gut microbiota can metabolize dietary- and host-derived factors to produce numerous microbial metabolites, which are involved in metabolic processes modulating nutrition and energy harvest, gut barrier function, systemic inflammation, and glucose metabolism. Microbial metabolites are important mediators of microbial-host crosstalk impacting host glucose metabolism. Furthermore, microbiome-based interventions may have beneficial effects on glycemic control. Future research is required to develop personalized T2D therapy based on microbial composition and/or metabolites.
A Systematic Review of Gut Microbiota Diversity: A Key Player in the Management and Prevention of Diabetes Mellitus

Hema Manvi Koneru,Hooria Sarwar,Venkata Varshitha Bandi,Mohit Sinha,Pakeeza Tarar,Rafik Bishara,Iana Malasevskaia

DOI: https://doi.org/10.7759/cureus.69687

2024-09-18

Cureus

Abstract:Diabetes mellitus represents a significant global health challenge, characterized by impaired insulin production and action, leading to elevated blood glucose levels. This systematic review investigates the association between gut microbiota composition and diversity, along with the structural and functional characteristics of the gut microbiome, and their implications for the risk, prevention, and management of both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, a comprehensive search across multiple databases yielded 16 studies that met the inclusion criteria. The findings highlight the potential of gut microbiota interventions, such as fecal microbiota transplantation and probiotic supplementation, in improving metabolic parameters and glycemic control. Notably, the review underscores the importance of dietary interventions and the role of specific microbial populations in influencing diabetes outcomes. Despite the promising results, the variability in study designs, sample sizes, and methodologies poses challenges for generalizability and interpretation. This review emphasizes the need for further research to elucidate the mechanisms underlying these associations and to explore personalized microbiome-based therapies in diabetes management. The insights gained could pave the way for innovative therapeutic strategies aimed at harnessing gut health to mitigate the burden of diabetes mellitus.
Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay.

C. D. Ley,M. B. Olsen,E. Lund,P. Kristjansen

DOI: https://doi.org/10.1016/J.MVR.2004.06.002

IF: 3.75

2004-11-01

Microvascular Research

Abstract:
The potential role of gut microbiota in the pathogenesis of type 2 diabetes mellitus via epigenetics and inflammasome.

Bunty Sharma,Aman Kumar,Ujjawal Sharma,Deeksha Pal,Sourabh Prashar

DOI: https://doi.org/10.2174/1871530322666220331152809

2022-03-31

Abstract:Abstract: The gut microbiota that comprises over 100 trillion microorganisms with a weight of about 1-2 kg is regarded as one of the most crucial players in the regulation of the metabolic health of host organisms. In recent years, the incidence of type 2 diabetes mellitus (T2DM), characterized by high levels of sugar in the blood, is exponentially increasing due to obesity and other lifestyle risk factors. It was shown that dysbiosis, change in the overall composition, and diversity of gut microflora can result in T2DM. Conversely, the microbial composition can also influence the epigenetics of the host organism (DNA methylation as well as histone modifications), which might have a potential effect on the metabolic health of the individual. Another mechanism of gut microbiota in the development of T2DM is through the involvement of nucleotide-binding oligomerization domain, Leucine-rich Repeat, and Pyrin domain containing 3 (NLRP3) inflammasome, a part of the innate immune system. NLRP3 inflammasome results in the production of inflammatory cytokines, promoting the secretion of microbial antigens in the intestinal epithelium. Therefore, it is important to understand the possible connecting link between gut microbiota and T2DM that might help in the modulation of gut microflora to better understand the disease. In this review, the role of gut microbiota in the pathogenesis of T2DM will be discussed.
The Role of Gut Microbiota in the Development of Type 2 Diabetes Mellitus

Okelue Okobi

DOI: https://doi.org/10.18103/mra.v12i7.5454

2024-01-01

Medical Research Archives

Abstract:Type 2 diabetes mellitus presents a significant global healthcare challenge with a steadily rising prevalence. Recent research has shed light on the correlation between gut bacteria and the improvement or progression of type 2 diabetes. This review article delves into an evaluation of current knowledge of how the gut microbiota affects type 2 diabetes, focusing on the impact of microbial imbalances on insulin resistance, inflammation, and metabolic dysfunction. By evaluating current knowledge in this field, the study highlights the potential of modifying the gut microbiota through food plan adjustments, probiotics, prebiotics, and fecal transplants as a promising strategy for managing type 2 diabetes. Additionally, it explores how specific microbial species and compounds influence glucose metabolism and insulin sensitivity, potentially providing targets for microbiota-focused interventions aimed at ameliorating the burden of type 2 diabetes.
Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes

Sabrina Donati Zeppa,Marco Gervasi,Alessia Bartolacci,Fabio Ferrini,Antonino Patti,Piero Sestili,Vilberto Stocchi,Deborah Agostini

DOI: https://doi.org/10.3390/nu16223951

IF: 5.9

2024-11-24

Nutrients

Abstract:Type 2 diabetes (T2D) is a chronic metabolic disorder with a heterogeneous etiology encompassing societal and behavioral risk factors in addition to genetic and environmental susceptibility. The cardiovascular consequences of diabetes account for more than two-thirds of mortality among people with T2D. Not only does T2D shorten life expectancy, but it also lowers quality of life and is associated with extremely high health expenditures since diabetic complications raise both direct and indirect healthcare costs. An increasing body of research indicates a connection between T2D and gut microbial traits, as numerous alterations in the intestinal microorganisms have been noted in pre-diabetic and diabetic individuals. These include pro-inflammatory bacterial patterns, increased intestinal permeability, endotoxemia, and hyperglycemia-favoring conditions, such as the alteration of glucagon-like peptide-1 (GLP-1) secretion. Restoring microbial homeostasis can be very beneficial for preventing and co-treating T2D and improving antidiabetic therapy outcomes. This review summarizes the characteristics of a "diabetic" microbiota and the metabolites produced by microbial species that can worsen or ameliorate T2D risk and progression, suggesting gut microbiota-targeted strategies to restore eubiosis and regulate blood glucose. Nutritional supplementation, diet, and physical exercise are known to play important roles in T2D, and here their effects on the gut microbiota are discussed, suggesting non-pharmacological approaches that can greatly help in diabetes management and highlighting the importance of tailoring treatments to individual needs.

nutrition & dietetics
Dosage of Haloperidol for Mania

A. Rifkin,S. Doddi,B. Karajgi,M. Borenstein,R. Munne

DOI: https://doi.org/10.1192/bjp.165.1.113

1994-07-01

Abstract:Background We compared three doses of a neuroleptic as a treatment for mania. Method Forty-seven newly admitted in-patients with mania were randomised to receive 10, 30, or 80 mg a day of oral haloperidol, under double-blind conditions for up to six weeks. All subjects received prophylactic benztropine. Results Repeated-measures analysis of variance and survival analysis showed no difference in outcome by the different doses. Excluding drop-outs (38%), most of whom left the study during the first two weeks, 72% of the subjects responded. Side-effects were minimal; there were no differences among the three doses. Non-responders received more adjunctive lorazepam than responders. Conclusions The limited data suggest that more than 10 mg a day of haloperidol offers no advantage in mania.
Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus

Ravi Kant,Lakshya Chandra,Vipin Verma,Priyanshu Nain,Diego Bello,Siddharth Patel,Subash Ala,Rashmi Chandra,Mc Anto Antony

DOI: https://doi.org/10.5662/wjm.v12.i4.246

2022-07-20

World Journal of Methodology

Abstract:Microorganisms including bacteria, viruses, protozoa, and fungi living in the gastrointestinal tract are collectively known as the gut microbiota. Dysbiosis is the imbalance in microbial composition on or inside the body relative to healthy state. Altered Firmicutes to Bacteroidetes ratio and decreased abundance of Akkermansia muciniphila are the predominant gut dysbiosis associated with the pathogenesis of type 2 diabetes mellitus (T2DM) and metabolic syndrome. Pathophysiological mechanisms linking gut dysbiosis, and metabolic diseases and their complications include altered metabolism of short-chain fatty acids and bile acids, interaction with gut hormones, increased gut microbial metabolite trimethylamine-N-oxide, bacterial translocation/Leaky gut syndrome, and endotoxin production such as lipopolysaccharides. The association between the gut microbiota and glycemic agents, however, is much less understood and is the growing focus of research and conversation. Recent studies suggest that the gut microbiota and anti-diabetic medications are interdependent on each other, meaning that while anti-diabetic medications alter the gut microbiota, the gut microbiota also alters the efficacy of anti-diabetic medications. With increasing evidence regarding the significance of gut microbiota, it is imperative to review the role of gut microbiota in the pathogenesis of T2DM. This review also discusses the interaction between gut microbiota and the various medications used in the treatment of T2DM.
The underlying causes, treatment options of gut microbiota and food habits in type 2 diabetes mellitus: a narrative review

Krishnendu Adhikary,Riya Sarkar,Sriparna Maity,Ipsita Banerjee,Prity Chatterjee,Koushik Bhattacharya,Deepika Ahuja,Nirmalya Kumar Sinha,Rajkumar Maiti

DOI: https://doi.org/10.1515/jbcpp-2024-0043

2024-05-17

Journal of Basic and Clinical Physiology and Pharmacology

Abstract:Type 2 diabetes mellitus is a long-lasting endocrine disorder characterized by persistent hyperglycaemia, which is often triggered by an entire or relative inadequacy of insulin production or insulin resistance. As a result of resistance to insulin (IR) and an overall lack of insulin in the body, type 2 diabetes mellitus (T2DM) is a metabolic illness that is characterized by hyperglycaemia. Notably, the occurrence of vascular complications of diabetes and the advancement of IR in T2DM are accompanied by dysbiosis of the gut microbiota. Due to the difficulties in managing the disease and the dangers of multiple accompanying complications, diabetes is a chronic, progressive immune-mediated condition that plays a significant clinical and health burden on patients. The frequency and incidence of diabetes among young people have been rising worldwide. The relationship between the gut microbiota composition and the physio-pathological characteristics of T2DM proposes a novel way to monitor the condition and enhance the effectiveness of therapies. Our knowledge of the microbiota of the gut and how it affects health and illness has changed over the last 20 years. Species of the genus Eubacterium, which make up a significant portion of the core animal gut microbiome, are some of the recently discovered 'generation' of possibly helpful bacteria. In this article, we have focused on pathogenesis and therapeutic approaches towards T2DM, with a special reference to gut bacteria from ancient times to the present day.
The Effects of Diet Intervention on the Gut Microbiota in Type 2 Diabetes Mellitus: A Systematic Review

Kiana Farahbod,Ethan Slouha,Andrew Gerts,Atbeen Rezazadah,Lucy A Clunes,Theofanis F Kollias

DOI: https://doi.org/10.7759/cureus.56737

2024-03-22

Cureus

Abstract:The GI tract hosts a dynamic community known as the gut microbiota, which encompasses thriving bacteria that actively contribute to the physiological functions of the human body. The intricacies of its composition are profoundly influenced by dietary preferences, where the quality, quantity, and frequency of food consumption play a pivotal role in either fostering or impeding specific bacterial strains. Type 2 diabetes mellitus (T2DM) is a prevalent and deleterious condition that originates from excessive hyperglycemia. Do lifestyle interventions targeting dietary adjustments, nutritional supplements, physical activity, and weight management programs exhibit a significant relationship in altering the composition of the gut microbiome and managing T2DM? This paper aims to evaluate the effects of lifestyle interventions on patients with T2DM and the implications of these changes on disease outcomes and progression. Lifestyle interventions can significantly impact the management of T2DM, especially those targeting dietary adjustments, nutritional supplements, physical activity, and weight management programs. The adoption of a high-fiber diet and increased fruit consumption have shown positive impacts on both insulin sensitivity and the composition of the gut microbiota. Additionally, promising outcomes emerge from supplementing with Omega-3 fatty acids, Vitamin K2 (MK-7), and transglucosidase, which influence insulin levels, glycemic control, and gut microbiota composition. Personalized diet interventions and the transformative effects of the Mediterranean diet present positive outcomes in metabolic control. The intensity of exercise plays a pivotal role in shaping the composition of the gut microbiota, with moderate-intensity continuous exercise displaying positive effects on anti-inflammatory microbes. Chronic exercise showcases favorable impacts on glycemic control and systemic inflammation. Emphasizing the intricate relationship between dietary habits, gut microbiota, and the risk of T2DM underscores the potential of the gut microbiota as a universal biomarker for assessing diabetes risk. Nutritional supplements and exercise interventions provide potential avenues for the management of T2DM, emphasizing the necessity for tailored strategies. Further research is encouraged to delve into the long-term effects and intricate interplay between lifestyle factors and the gut microbiome, enhancing our understanding of T2DM pathophysiology for targeted therapeutic approaches.
Microbial Regulation of Glucose Metabolism and Insulin Resistance

Silke Crommen,Marie-Christine Simon

DOI: https://doi.org/10.3390/genes9010010

IF: 4.141

2017-12-29

Genes

Abstract:Type 2 diabetes is a combined disease, resulting from a hyperglycemia and peripheral and hepatic insulin resistance. Recent data suggest that the gut microbiota is involved in diabetes development, altering metabolic processes including glucose and fatty acid metabolism. Thus, type 2 diabetes patients show a microbial dysbiosis, with reduced butyrate-producing bacteria and elevated potential pathogens compared to metabolically healthy individuals. Furthermore, probiotics are a known tool to modulate the microbiota, having a therapeutic potential. Current literature will be discussed to elucidate the complex interaction of gut microbiota, intestinal permeability and inflammation leading to peripheral and hepatic insulin resistance. Therefore, this review aims to generate a deeper understanding of the underlying mechanism of potential microbial strains, which can be used as probiotics.

genetics & heredity

[REM sleep and intracranial pressure].

Exploring the Roles of Family Members in Women’s Decision to Use Postpartum Healthcare Services from the Perspectives of Women and Health Care Providers

Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus

Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus

The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes

Gut microbiome: A revolution in type II diabetes mellitus

The Gut Microbial Endocrine Organ in Type 2 Diabetes

Gut Microbiota and Nutrition: Strategies for the Prevention and Treatment of Type 2 Diabetes

Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus

The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes

Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes

A Systematic Review of Gut Microbiota Diversity: A Key Player in the Management and Prevention of Diabetes Mellitus

Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay.

The potential role of gut microbiota in the pathogenesis of type 2 diabetes mellitus via epigenetics and inflammasome.

The Role of Gut Microbiota in the Development of Type 2 Diabetes Mellitus

Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes

Dosage of Haloperidol for Mania

Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus

The underlying causes, treatment options of gut microbiota and food habits in type 2 diabetes mellitus: a narrative review

The Effects of Diet Intervention on the Gut Microbiota in Type 2 Diabetes Mellitus: A Systematic Review

Microbial Regulation of Glucose Metabolism and Insulin Resistance